Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer.

Takahashi Y, Sawada G, Kurashige J, Uchi R, Matsumura T, Ueo H, Takano Y, Akiyoshi S, Eguchi H, Sudo T, Sugimachi K, Doki Y, Mori M, Mimori K.

Br J Cancer. 2013 Jul 23;109(2):307-11. doi: 10.1038/bjc.2013.339. Epub 2013 Jun 27.

2.

Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

Ocaña OH, Córcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S, Barrallo-Gimeno A, Cano A, Nieto MA.

Cancer Cell. 2012 Dec 11;22(6):709-24. doi: 10.1016/j.ccr.2012.10.012. Epub 2012 Nov 29.

3.

Down-regualtion of miR-106b induces epithelial-mesenchymal transition but suppresses metastatic colonization by targeting Prrx1 in colorectal cancer.

Zheng L, Zhang Y, Lin S, Sun A, Chen R, Ding Y, Ding Y.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):10534-44. eCollection 2015.

4.

The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition.

Sun J, Ding C, Yang Z, Liu T, Zhang X, Zhao C, Wang J.

J Transl Med. 2016 Feb 8;14:42. doi: 10.1186/s12967-016-0786-z.

5.

STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer.

Zhang Z, Liu X, Feng B, Liu N, Wu Q, Han Y, Nie Y, Wu K, Shi Y, Fan D.

Oncogene. 2015 Sep 10;34(37):4808-20. doi: 10.1038/onc.2014.404. Epub 2014 Dec 22.

6.

MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.

Hur K, Toiyama Y, Takahashi M, Balaguer F, Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR, Goel A.

Gut. 2013 Sep;62(9):1315-26. doi: 10.1136/gutjnl-2011-301846. Epub 2012 Jun 26.

7.

Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer.

Lv ZD, Yang ZC, Liu XP, Jin LY, Dong Q, Qu HL, Li FN, Kong B, Sun J, Zhao JJ, Wang HB.

J Cell Mol Med. 2016 Sep;20(9):1640-50. doi: 10.1111/jcmm.12856. Epub 2016 Mar 29.

8.
9.

miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2.

Zheng YB, Luo HP, Shi Q, Hao ZN, Ding Y, Wang QS, Li SB, Xiao GC, Tong SL.

World J Gastroenterol. 2014 Jun 7;20(21):6515-22. doi: 10.3748/wjg.v20.i21.6515.

10.

OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer.

Zhou Y, Wu J, Fu X, Du W, Zhou L, Meng X, Yu H, Lin J, Ye W, Liu J, Peng H, Liu RY, Pan C, Huang W.

Mol Cancer. 2014 Nov 28;13:258. doi: 10.1186/1476-4598-13-258.

11.

MiR-124 Radiosensitizes human colorectal cancer cells by targeting PRRX1.

Zhang Y, Zheng L, Huang J, Gao F, Lin X, He L, Li D, Li Z, Ding Y, Chen L.

PLoS One. 2014 Apr 4;9(4):e93917. doi: 10.1371/journal.pone.0093917. eCollection 2014.

12.

SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation.

Ono H, Imoto I, Kozaki K, Tsuda H, Matsui T, Kurasawa Y, Muramatsu T, Sugihara K, Inazawa J.

Oncogene. 2012 Nov 22;31(47):4923-34. doi: 10.1038/onc.2011.646. Epub 2012 Jan 30.

PMID:
22286765
13.

Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer.

Meng HM, Zheng P, Wang XY, Liu C, Sui HM, Wu SJ, Zhou J, Ding YQ, Li J.

Cancer Biol Ther. 2010 Feb;9(4):295-302. doi: 10.4161/cbt.9.4.10666. Epub 2009 Dec 22.

PMID:
20026903
14.

SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression.

Cheng F, Su L, Yao C, Liu L, Shen J, Liu C, Chen X, Luo Y, Jiang L, Shan J, Chen J, Zhu W, Shao J, Qian C.

Cancer Lett. 2016 Jun 1;375(2):274-283. doi: 10.1016/j.canlet.2016.03.010. Epub 2016 Mar 11.

PMID:
26975631
15.
16.

MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling.

Zhang JX, Mai SJ, Huang XX, Wang FW, Liao YJ, Lin MC, Kung HF, Zeng YX, Xie D.

Ann Oncol. 2014 Nov;25(11):2196-204. doi: 10.1093/annonc/mdu439. Epub 2014 Sep 5.

PMID:
25193986
17.

The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progression.

Hardin H, Guo Z, Shan W, Montemayor-Garcia C, Asioli S, Yu XM, Harrison AD, Chen H, Lloyd RV.

Am J Pathol. 2014 Aug;184(8):2342-54. doi: 10.1016/j.ajpath.2014.04.011. Epub 2014 Jun 17.

18.

SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.

Hwang WL, Yang MH, Tsai ML, Lan HY, Su SH, Chang SC, Teng HW, Yang SH, Lan YT, Chiou SH, Wang HW.

Gastroenterology. 2011 Jul;141(1):279-91, 291.e1-5. doi: 10.1053/j.gastro.2011.04.008. Epub 2011 Apr 16.

PMID:
21640118
19.

Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma.

Hirata H, Sugimachi K, Takahashi Y, Ueda M, Sakimura S, Uchi R, Kurashige J, Takano Y, Nanbara S, Komatsu H, Saito T, Shinden Y, Iguchi T, Eguchi H, Atsumi K, Sakamoto K, Doi T, Hirakawa M, Honda H, Mimori K.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1402-9. doi: 10.1245/s10434-014-4242-0. Epub 2014 Nov 18.

PMID:
25404478
20.

Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.

Xiong H, Hong J, Du W, Lin YW, Ren LL, Wang YC, Su WY, Wang JL, Cui Y, Wang ZH, Fang JY.

J Biol Chem. 2012 Feb 17;287(8):5819-32. doi: 10.1074/jbc.M111.295964. Epub 2011 Dec 28.

Supplemental Content

Support Center